Literature DB >> 8058724

Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis.

C Ramazeilles1, R K Mishra, S Moreau, E Pascolo, J J Toulmé.   

Abstract

We targeted the mini-exon sequence, present at the 5' end of every mRNA of the protozoan parasite Leishmania amazonensis, by phosphorothioate oligonucleotides. A complementary 16-mer (16PS) was able to kill amastigotes--the intracellular stage of the parasite--in murine macrophages in culture. After 24 hr of incubation with 10 microM 16PS, about 30% infected macrophages were cured. The oligomer 16PS acted through antisense hybridization in a sequence-dependent way; no effect on parasites was observed with noncomplementary phosphorothioate oligonucleotides. The antisense oligonucleotide 16PS was a selective killer of the protozoans without any detrimental effect to the host macrophage. Using 16PS linked to a palmitate chain, which enabled it to complex with low density lipoproteins, improved the leishmanicidal efficiency on intracellular amastigotes, probably due to increased endocytosis. Phosphorothioate oligonucleotides complementary to the intron part of the mini-exon pre-RNA were also effective, suggesting that antisense oligomers could prevent trans-splicing in these parasites.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058724      PMCID: PMC44503          DOI: 10.1073/pnas.91.17.7859

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The use of single-stranded DNA and RNase H to promote quantitative 'hybrid arrest of translation' of mRNA/DNA hybrids in reticulocyte lysate cell-free translations.

Authors:  J Minshull; T Hunt
Journal:  Nucleic Acids Res       Date:  1986-08-26       Impact factor: 16.971

2.  Cloning and characterization of a Leishmania gene encoding a RNA spliced leader sequence.

Authors:  S I Miller; S M Landfear; D F Wirth
Journal:  Nucleic Acids Res       Date:  1986-09-25       Impact factor: 16.971

3.  alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition.

Authors:  C Gagnor; J R Bertrand; S Thenet; M Lemaître; F Morvan; B Rayner; C Malvy; B Lebleu; J L Imbach; C Paoletti
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

4.  The common 5' terminal sequence on trypanosome mRNAs: a target for anti-messenger oligodeoxynucleotides.

Authors:  A W Cornelissen; M P Verspieren; J J Toulmé; B W Swinkels; P Borst
Journal:  Nucleic Acids Res       Date:  1986-07-25       Impact factor: 16.971

5.  Quantitative release of live microorganisms from infected macrophages by sodium dodecyl sulphate.

Authors:  J Mauel; R Behin
Journal:  Nat New Biol       Date:  1973-07-18

Review 6.  Discontinuous transcription and antigenic variation in trypanosomes.

Authors:  P Borst
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

7.  The 35-nucleotide spliced leader sequence is common to all trypanosome messenger RNA's.

Authors:  J A Walder; P S Eder; D M Engman; S T Brentano; R Y Walder; D S Knutzon; D M Dorfman; J E Donelson
Journal:  Science       Date:  1986-08-01       Impact factor: 47.728

Review 8.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

Authors:  C A Stein; Y C Cheng
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

9.  A simple and efficient procedure for the synthesis of 5'-aminoalkyl oligodeoxynucleotides.

Authors:  L Wachter; J A Jablonski; K L Ramachandran
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

10.  Destruction of Leishmania mexicana amazonensis amastigotes within macrophages by lysosomotropic amino acid esters.

Authors:  M Rabinovitch; V Zilberfarb; C Ramazeilles
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  14 in total

1.  Ligation of Fc receptor of macrophages stimulates protein kinase C and anti-leishmanial activity.

Authors:  D Dasgupta; P Chakraborty; M K Basu
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

2.  Extrachromosomal, homologous expression of trypanothione reductase and its complementary mRNA in Trypanosoma cruzi.

Authors:  J Tovar; A H Fairlamb
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

3.  Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania.

Authors:  R Chakraborty; D Dasgupta; S Adhya; M K Basu
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

4.  Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H.

Authors:  M Mishra; J R Bennett; G Chaudhuri
Journal:  Biochem Pharmacol       Date:  2001-02-15       Impact factor: 5.858

5.  Scavenger receptor-mediated delivery of antisense mini-exon phosphorothioate oligonucleotide to Leishmania-infected macrophages. Selective and efficient elimination of the parasite.

Authors:  G Chaudhuri
Journal:  Biochem Pharmacol       Date:  1997-02-07       Impact factor: 5.858

6.  Targeted reduction in expression of Trypanosoma cruzi surface glycoprotein gp90 increases parasite infectivity.

Authors:  S Málaga; N Yoshida
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  Expression of an antisense hla fragment in Staphylococcus aureus reduces alpha-toxin production in vitro and attenuates lethal activity in a murine model.

Authors:  D S Kernodle; R K Voladri; B E Menzies; C C Hager; K M Edwards
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 8.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

9.  Antimycobacterial activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant strains.

Authors:  E Rapaport; A Levina; V Metelev; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

10.  Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides.

Authors:  R H Barker; V Metelev; E Rapaport; P Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.